TSHA
Taysha Gene Therapies Inc

2,021
Mkt Cap
$1.26B
Volume
5.04M
52W High
$6.02
52W Low
$1.05
PE Ratio
-13.00
TSHA Fundamentals
Price
$4.49
Prev Close
$4.61
Open
$4.63
50D MA
$4.75
Beta
1.62
Avg. Volume
2.29M
EPS (Annual)
-$0.357
P/B
5.77
Rev/Employee
$114,150.68
$357.20
Loading...
Loading...
News
all
press releases
Jefferies Financial Group Inc. Sells 8,157,091 Shares of Taysha Gene Therapies, Inc. $TSHA
Jefferies Financial Group Inc. decreased its holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 79.1% during the 3rd quarter, according to the company in its most recent...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twelve brokerages that are covering the stock, Marketbeat...
MarketBeat·18d ago
News Placeholder
GSA Capital Partners LLP Increases Holdings in Taysha Gene Therapies, Inc. $TSHA
GSA Capital Partners LLP raised its stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 969.0% during the third quarter, according to the company in its most recent Form 13F filing...
MarketBeat·24d ago
News Placeholder
Taysha Gene Therapies (TSHA) Projected to Post Quarterly Earnings on Wednesday
Taysha Gene Therapies (NASDAQ:TSHA) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...
MarketBeat·24d ago
News Placeholder
Commit To Buy Taysha Gene Therapies At $2.50, Earn 16.8% Annualized Using Options
Investors eyeing a purchase of Taysha Gene Therapies Inc (Symbol: TSHA) shares, but tentative about paying the going market price of $4.61/share, might benefit from considering selling puts among the...
Nasdaq News: Markets·25d ago
News Placeholder
Taysha Gene Therapies, Inc. $TSHA Shares Sold by SG Americas Securities LLC
SG Americas Securities LLC cut its holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 93.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund...
MarketBeat·1mo ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Trading Down 6.2% - What's Next?
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Down 6.2% - Here's What Happened...
MarketBeat·2mo ago
News Placeholder
Sukumar Nagendran Sells 200,000 Shares of Taysha Gene Therapies (NASDAQ:TSHA) Stock
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) insider Sukumar Nagendran sold 200,000 shares of the firm's stock in a transaction that occurred on Monday, January 12th. The stock was...
MarketBeat·2mo ago
News Placeholder
Insider Selling: Taysha Gene Therapies (NASDAQ:TSHA) Insider Sells 200,000 Shares of Stock
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) insider Sukumar Nagendran sold 200,000 shares of the company's stock in a transaction that occurred on Monday, January 12th. The stock was...
MarketBeat·2mo ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Trading Down 6.3% - Should You Sell?
Taysha Gene Therapies (NASDAQ:TSHA) Shares Down 6.3% - Time to Sell...
MarketBeat·2mo ago
<
1
2
...
>

Latest TSHA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.